Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
Clonal cytogenetic abnormalities are found in 20-30% of patients with chronic myelomonocytic leukemia (CMML), while gene mutations are present in.
| Autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2016 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:185942 |
| Acceso en línea: | https://ddd.uab.cat/record/185942 https://dx.doi.org/urn:doi:10.18632/oncotarget.10937 |
| Access Level: | acceso abierto |
| Palabra clave: | Chronic myelomonocytic leukemia Normal karyotype Gene mutations Targeted deep sequencing Prognostic factors |
| Sumario: | Clonal cytogenetic abnormalities are found in 20-30% of patients with chronic myelomonocytic leukemia (CMML), while gene mutations are present in. |
|---|